Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
Intravenous ciprofloxacin therapy was evaluated in comparison with i.v. ceftazidime in the treatment of skin and soft tissue infections and were found to be comparable. Intravenous or peroral forms of ciprofloxacin may be used instead of intravenously given third generation cephalosporins or aminoglycosides in the treatment of even severe infections of the skin and soft tissue.
Thadepalli
H
H
Division of Infectious Diseases, Martin Luther King, Jr. General Hospital, Drew University School of Medicine and Science, Los Angeles, CA 90059.
Mathai
D
D
Chuah
S K
SK
Bansal
M B
MB
D000284:Administration, Oral; D001424:Bacterial Infections / Q000188:drug therapy*; D002442:Ceftazidime / Q000009:adverse effects / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003240:Connective Tissue Diseases / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D011446:Prospective Studies; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D002939:Ciprofloxacin; D002442:Ceftazidime